• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Life Sciences | News, Analysis, Insights - HIT Consultant

DHL Express Launches Next-Day Brazil-to-USA Medical Express Service for Clinical Trials

by Fred Pennic 04/24/2025 Leave a Comment

DHL Express Launches Next-Day Brazil-to-USA Medical Express Service for Clinical Trials

What You Should Know:  - DHL Express, the world's leading international express services provider, today announced a significant expansion of its specialized Medical Express (WMX) service, adding a next-day delivery capability for the critical Brazil-to-USA lane.  - The enhancement connects South America and Puerto Rico more efficiently to the United States, providing crucial support for customers in the pharmaceutical and clinical research sectors navigating complex global
Read More

Eli Lilly’s Oral GLP-1 Shows Positive Trial Results for Type 2 Diabetes

by Jasmine Pennic 04/17/2025 Leave a Comment

Lilly's Oral GLP-1 Shows Positive Phase 3 Results for Type 2 Diabetes

What You Should Know:  - Eli Lilly and Company announced positive topline Phase 3 results from ACHIEVE-1, a study evaluating the safety and efficacy of orforglipron compared to placebo in adults with type 2 diabetes whose blood sugar was inadequately controlled through diet and exercise alone.  - Orforglipron stands out as the first oral small molecule glucagon-like peptide-1 (GLP-1) receptor agonist, taken without food and water restrictions, to successfully complete a Phase 3
Read More

The AI Hype Cycle in MedTech: Navigating the Trough of Disillusionment

by Adam Hesse, CEO at Full Spectrum 04/15/2025 Leave a Comment

The AI Hype Cycle in MedTech: Navigating the Trough of Disillusionment

The emerging technologies hype cycle had multiple AI applications at the peak of inflated expectations in 2023 and were just beginning the ride down to the Trough of Disillusionment in 20241 2. For years, it’s been said that “the use of data and algorithms is going to transform healthcare.” While true to a degree, we see that MedTech companies that invest in trends like artificial neural networks, analytics, big data analytics, and now AI, often struggle to yield a significant return on
Read More

Sware & Salesforce Partner to Bring AI-Driven Technology to the Life Sciences Cloud

by Syed Hamza Sohail 04/15/2025 Leave a Comment

Sware & Salesforce Partner to Bring AI-Driven Technology to the Life Sciences Cloud

What You Should Know: -  Sware, the leading provider of comprehensive GxP validation solutions for innovative life sciences and technology companies, today announced that it will deliver GxP computer systems validation of Salesforce Life Sciences Cloud.  -   Life Sciences Cloud empowers pharmaceutical and medical technology organizations to accelerate drug and device development, recruit and retain patients across clinical trials, and leverage AI to deliver personalized customer
Read More

How Are Advances in Neurologic Technology Changing Diagnosis and Treatment?

by Fred Pennic 04/11/2025 Leave a Comment

How Are Advances in Neurologic Technology Changing Diagnosis and Treatment?

From sophisticated imaging techniques to gene therapies and artificial intelligence, the landscape of neurological care is evolving at an unprecedented pace. These innovations are revolutionizing how we diagnose and treat neurological disorders, offering hope for improved outcomes and a better quality of life for millions affected by conditions impacting the brain, spinal cord, and peripheral nerves.  Advanced Neuroimaging One of the most significant areas of progress lies in
Read More

illumicell AI Raises $2M to Transform Semen Diagnostics with Real-Time AI

by Fred Pennic 04/10/2025 Leave a Comment

illumicell AI Raises $2M to Transform Semen Diagnostics with Real-Time AI

What You Should Know:  - Techmed startup illumicell AI, founded by a team of Harvard-trained physician Michel Bielecki, former McKinsey consultant Jeyla Sadikova, and rocket engineer Loup Cordey, has secured $2M in pre-seed funding. The funding round was supported by a combination of healthcare operators, clinicians, and early-stage funds, including life science investors KOFA Healthcare, Harvard Phoenix Venture Fund, and MedTechSyndicates - The company aims to transform fluid-based
Read More

Flatiron Health and Massive Bio Partner to Improve Clinical Trial Enrollment

by Jasmine Pennic 04/07/2025 Leave a Comment

Flatiron Health and Massive Bio Partner to Improve Clinical Trial Enrollment

What You Should Know:  - Flatiron Health, a healthtech company focused on transforming clinical research through technology that integrates research into everyday care, has announced a strategic partnership with Massive Bio, a global leader in using artificial intelligence to streamline patient identification and recruitment for clinical trials. - The partnership aims to expand patient identification capabilities and improve clinical trial enrollment across the U.S.  Enhance
Read More

Simplifying Clinical Trials: Addressing Technology Challenges for Site Teams

by Rajneesh Patil, Vice President, Digital Innovation & Nicholas Whitney​, Senior Director, Site Suite at IQVIA 04/04/2025 Leave a Comment

Simplifying Clinical Trials: Addressing Technology Challenges for Site Teams

In recent years, clinical research and development stakeholders have put tremendous effort into improving patient-centered clinical trials, where patients feel valued as partners in the processes and approaches to care that impact their health. Clinical trial sponsors are keenly aware that, to do so, the use of advanced clinical technologies, including decentralized solutions, has been necessary to improve patient experience and accelerate drug development. But as sponsors implement multiple
Read More

How 3D Modeling is Transforming Medical Imaging and Diagnosis

by Nik Froehlich, CEO and Founder of Saritasa 03/26/2025 Leave a Comment

How 3D Modeling is Transforming Medical Imaging and Diagnosis

In the 21st century, we are fortunate to benefit from perpetual advances in medicine. Researchers continue to discover new procedures and treatments, and those advances often rely on technology. Improvements in hardware, internet speeds, interconnected devices, and artificial intelligence all contribute to higher efficiency, personalization, and accessibility in treatments.  Technologies such as advanced imaging and modeling (AIM), augmented reality/virtual reality (AR/VR), 3D printers,
Read More

Pharma R&D Returns Surge in 2024, Driven by GLP-1 Therapies, Despite Rising Costs

by Fred Pennic 03/25/2025 Leave a Comment

Pharma R&D Returns Surge in 2024, Driven by GLP-1 Therapies, Despite Rising Costs

What You Should Know:  - The pharmaceutical research and development (R&D) sector is experiencing a significant upswing, with projected returns on investment climbing to 5.9% in 2024, according to a new report by Deloitte.  - This surge, building on 2023’s 4.1%, is largely attributed to the success of GLP-1 therapies, showcasing the lucrative potential of addressing substantial unmet medical needs. However, this positive trend is juxtaposed with rising drug development costs
Read More

  • Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Interim pages omitted …
  • Go to page 84
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Kinetik CEO Sufian Chowdhury on Fighting NEMT Fraud & Waste

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |